Less-toxic drug prolongs survival in metastatic breast cancer

CHICAGO --- Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug.

Read the whole article on Science Blog

More from Science Blog